Method for producing a drug delivery system

Inventors

Schneeberger, Achim • Kühne, Klaus • KERSCHBAUMER, Helmut • VASIC, Srdan

Assignees

Laxxon Medical AG • Exentis Knowledge GmbH • Exentis Knowldege GmbH

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12290605-B2

Patent

Publication Date

2025-05-06

Expiration Date


Abstract

The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.

Core Innovation

The invention provides a method for producing a drug delivery system by sequential screen-printing and curing a base paste and a separate first paste. The first paste comprises a therapeutically effective amount of a first active pharmaceutical ingredient, and both the base paste and the first paste are soluble in body fluids so that the resulting drug delivery system is soluble in body fluids.

In the resulting drug delivery system, the first paste is arranged inhomogeneously in the base paste, including through a three-dimensional arrangement throughout the base paste along three dimensions. The method produces an inhomogeneous arrangement so that the concentration of the first active pharmaceutical ingredient varies throughout the drug delivery system, and a transition from an area with a high concentration to an area with a low concentration is smooth rather than abrupt.

The concentration profile is configured such that, upon application of the drug delivery system, release of the first active pharmaceutical ingredient occurs at a varying rate. The first active pharmaceutical ingredient is an anticancer agent, and the inhomogeneous three-dimensional concentration profile produced by screen-printing and curing is linked to predetermined release behavior characterized by varying release rate.

Claims Coverage

The claim coverage includes one independent claim with three inventive features centered on producing a soluble drug delivery system by screen-printing and curing a base paste and a separate API-containing paste to form a smooth, three-dimensional, inhomogeneous concentration profile that yields a varying release rate for an anticancer agent. Dependent claims refine release-profile and concentration-profile constraints, and optionally add a second API with phasing behavior.

Soluble drug delivery system formed by sequential screen-printing and curing

Screen-printing a base paste, curing the base paste, screen-printing a first paste separate to the base paste, and curing the first paste, wherein the first paste comprises a therapeutically effective amount of a first active pharmaceutical ingredient and the base paste and the first paste are soluble in body fluids such that the resulting drug delivery system is soluble in body fluids.

Three-dimensional inhomogeneous arrangement of the first paste

Screen-printing the pastes such that the first paste is inhomogeneously arranged in the base paste, with the base paste provided as a three-dimensional body and the separate first paste inhomogeneously arranged throughout the base paste along the three dimensions.

Smooth high-to-low API concentration transition with varying-rate release

Screen-printing the pastes such that the concentration of the first active pharmaceutical ingredient varies throughout the drug delivery system, with a smooth transition from an area with a high concentration to an area with a low concentration, and such that upon application the release of the first active pharmaceutical ingredient occurs at a varying rate, wherein the first active pharmaceutical ingredient is an anticancer agent.

Overall, the claim coverage centers on forming a soluble drug delivery system by separately screen-printing and curing an API-containing paste in an inhomogeneous, three-dimensional manner within a base paste, producing a smooth high-to-low concentration transition tied to varying release rate upon application for an anticancer agent.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.